Skip to main content

ASMANEX TWISTHALER

ICS DPI

Mometasone furoate · Organon

Clinical Reference · Data reviewed June 2026

Active Medication & Mechanism

  • Mometasone furoate ICS
    110 mcg or 220 mcg per actuation (delivers 100 mcg or 200 mcg from mouthpiece)

    Synthetic corticosteroid with potent anti-inflammatory properties. Reduces airway inflammation.

FDA-Approved Dosing — Strength × Indication

220 mcg
Asthma FDA Approved
Adults (previously on bronchodilators alone or ICS) 1 inhalation once daily in the evening or 1 inhalation twice daily → 220–440 mcg Recommended starting dose: 220 mcg once daily in the evening. Highest recommended dose 440 mcg/day, given as 220 mcg twice daily or 440 mcg once daily in the evening.
Adults (previously on oral corticosteroids) 2 inhalations twice daily → 880 mcg Maximum recommended dose. For patients previously on oral corticosteroids.

All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling

Not a rescue inhaler. Not for acute use. Use a SABA.

Related Inhalers

For educational reference by healthcare professionals. Not medical advice and not for use in clinical decision-making. This workspace is not a substitute for clinical judgement, prescribing information, or product monographs — always verify doses and indications against the most current labelling. If you are a patient, do not use this site to make medication decisions — speak with your clinician.

Device images are original illustrations for identification aid only — actual devices and packaging may differ. This site is not affiliated with or endorsed by any pharmaceutical manufacturer. Clinical data last reviewed: June 2026.

Inhaler Database · © inhalerdatabase.com 2024–2026 — All rights reserved